Zdrowie i gospodarka · 07/07/2015

FDA Revokes CHEMBIOMED's U.S. License for Manufacturing Monoclonal Antibodies

The US Food and Drug Administration (FDA) has revoked CHEMBIOMED's license to manufacture certain monoclonal antibodies, following the company's failure to respond to a notice regarding a proposal to revoke its license.